nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2B—Sorafenib—kidney cancer	0.0628	0.114	CbGbCtD
Mirtazapine—HTR2C—Sorafenib—kidney cancer	0.0409	0.0743	CbGbCtD
Mirtazapine—CYP2D6—Temsirolimus—kidney cancer	0.0402	0.0731	CbGbCtD
Mirtazapine—CYP3A4—Everolimus—kidney cancer	0.0379	0.0688	CbGbCtD
Mirtazapine—CYP2C8—Pazopanib—kidney cancer	0.0331	0.0602	CbGbCtD
Mirtazapine—CYP1A2—Pazopanib—kidney cancer	0.0256	0.0466	CbGbCtD
Mirtazapine—CYP3A4—Temsirolimus—kidney cancer	0.0256	0.0465	CbGbCtD
Mirtazapine—CYP2C9—Capecitabine—kidney cancer	0.0241	0.0438	CbGbCtD
Mirtazapine—CYP2C8—Erlotinib—kidney cancer	0.0236	0.043	CbGbCtD
Mirtazapine—CYP2C8—Paclitaxel—kidney cancer	0.0216	0.0393	CbGbCtD
Mirtazapine—CYP2D6—Pazopanib—kidney cancer	0.0211	0.0384	CbGbCtD
Mirtazapine—CYP2C8—Sorafenib—kidney cancer	0.0192	0.0349	CbGbCtD
Mirtazapine—CYP1A2—Erlotinib—kidney cancer	0.0183	0.0332	CbGbCtD
Mirtazapine—CYP2C9—Paclitaxel—kidney cancer	0.0151	0.0274	CbGbCtD
Mirtazapine—CYP2D6—Erlotinib—kidney cancer	0.0151	0.0274	CbGbCtD
Mirtazapine—CYP1A2—Sorafenib—kidney cancer	0.0149	0.027	CbGbCtD
Mirtazapine—CYP3A4—Pazopanib—kidney cancer	0.0134	0.0244	CbGbCtD
Mirtazapine—CYP2C9—Sorafenib—kidney cancer	0.0134	0.0244	CbGbCtD
Mirtazapine—CYP2D6—Sorafenib—kidney cancer	0.0123	0.0223	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—kidney cancer	0.0121	0.022	CbGbCtD
Mirtazapine—CYP3A4—Erlotinib—kidney cancer	0.00958	0.0174	CbGbCtD
Mirtazapine—CYP3A4—Paclitaxel—kidney cancer	0.00877	0.0159	CbGbCtD
Mirtazapine—CYP3A4—Sorafenib—kidney cancer	0.00779	0.0142	CbGbCtD
Mirtazapine—CYP3A4—Vinblastine—kidney cancer	0.0077	0.014	CbGbCtD
Mirtazapine—CYP3A4—Vincristine—kidney cancer	0.00757	0.0137	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—kidney cancer	0.00744	0.0135	CbGbCtD
Mirtazapine—CYP3A4—Sunitinib—kidney cancer	0.00631	0.0115	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—kidney cancer	0.00473	0.00859	CbGbCtD
Mirtazapine—CYP1A2—urine—kidney cancer	0.00118	0.0942	CbGeAlD
Mirtazapine—CYP2C9—urine—kidney cancer	0.00112	0.0894	CbGeAlD
Mirtazapine—HTR2A—urine—kidney cancer	0.00092	0.0737	CbGeAlD
Mirtazapine—CYP3A4—urine—kidney cancer	0.000852	0.0682	CbGeAlD
Mirtazapine—CYP2D6—urine—kidney cancer	0.000838	0.0671	CbGeAlD
Mirtazapine—HTR2B—cortex of kidney—kidney cancer	0.000397	0.0318	CbGeAlD
Mirtazapine—ADRB1—cardiac atrium—kidney cancer	0.000394	0.0316	CbGeAlD
Mirtazapine—HTR1A—renal system—kidney cancer	0.000378	0.0302	CbGeAlD
Mirtazapine—ADRA2C—nephron tubule—kidney cancer	0.000365	0.0292	CbGeAlD
Mirtazapine—HTR7—renal system—kidney cancer	0.000361	0.0289	CbGeAlD
Mirtazapine—HTR7—kidney—kidney cancer	0.000349	0.0279	CbGeAlD
Mirtazapine—ADRA1A—renal system—kidney cancer	0.000348	0.0279	CbGeAlD
Mirtazapine—SLC6A2—gonad—kidney cancer	0.000336	0.0269	CbGeAlD
Mirtazapine—ADRA2C—renal system—kidney cancer	0.000332	0.0266	CbGeAlD
Mirtazapine—HTR7—gonad—kidney cancer	0.000324	0.0259	CbGeAlD
Mirtazapine—ADRA2C—kidney—kidney cancer	0.000321	0.0257	CbGeAlD
Mirtazapine—ADRA2C—cortex of kidney—kidney cancer	0.000312	0.025	CbGeAlD
Mirtazapine—CYP2C8—renal system—kidney cancer	0.000308	0.0246	CbGeAlD
Mirtazapine—CYP2C8—kidney—kidney cancer	0.000297	0.0238	CbGeAlD
Mirtazapine—ADRA2C—cardiac atrium—kidney cancer	0.000297	0.0238	CbGeAlD
Mirtazapine—CYP1A2—renal system—kidney cancer	0.000288	0.0231	CbGeAlD
Mirtazapine—ADRA2A—cortex of kidney—kidney cancer	0.000249	0.02	CbGeAlD
Mirtazapine—ADRA2A—gonad—kidney cancer	0.000237	0.019	CbGeAlD
Mirtazapine—ADRA2A—cardiac atrium—kidney cancer	0.000237	0.019	CbGeAlD
Mirtazapine—HTR2A—renal system—kidney cancer	0.000225	0.018	CbGeAlD
Mirtazapine—HTR2A—kidney—kidney cancer	0.000218	0.0174	CbGeAlD
Mirtazapine—CYP3A4—renal system—kidney cancer	0.000208	0.0167	CbGeAlD
Mirtazapine—CYP2D6—renal system—kidney cancer	0.000205	0.0164	CbGeAlD
Mirtazapine—HTR2A—gonad—kidney cancer	0.000202	0.0162	CbGeAlD
Mirtazapine—CYP3A4—kidney—kidney cancer	0.000201	0.0161	CbGeAlD
Mirtazapine—CYP2D6—kidney—kidney cancer	0.000198	0.0159	CbGeAlD
Mirtazapine—Diarrhoea—Sunitinib—kidney cancer	0.000105	0.000295	CcSEcCtD
Mirtazapine—Ataxia—Doxorubicin—kidney cancer	0.000104	0.000293	CcSEcCtD
Mirtazapine—Mental disorder—Capecitabine—kidney cancer	0.000104	0.000293	CcSEcCtD
Mirtazapine—Asthenia—Dactinomycin—kidney cancer	0.000104	0.000293	CcSEcCtD
Mirtazapine—Confusional state—Paclitaxel—kidney cancer	0.000104	0.000292	CcSEcCtD
Mirtazapine—Malnutrition—Capecitabine—kidney cancer	0.000104	0.000291	CcSEcCtD
Mirtazapine—Dehydration—Doxorubicin—kidney cancer	0.000103	0.00029	CcSEcCtD
Mirtazapine—Oedema—Paclitaxel—kidney cancer	0.000103	0.000289	CcSEcCtD
Mirtazapine—Body temperature increased—Vincristine—kidney cancer	0.000103	0.000288	CcSEcCtD
Mirtazapine—Abdominal pain—Vincristine—kidney cancer	0.000103	0.000288	CcSEcCtD
Mirtazapine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000102	0.000288	CcSEcCtD
Mirtazapine—Infection—Paclitaxel—kidney cancer	0.000102	0.000288	CcSEcCtD
Mirtazapine—Flatulence—Capecitabine—kidney cancer	0.000102	0.000287	CcSEcCtD
Mirtazapine—Dry skin—Doxorubicin—kidney cancer	0.000102	0.000286	CcSEcCtD
Mirtazapine—Dysgeusia—Capecitabine—kidney cancer	0.000102	0.000285	CcSEcCtD
Mirtazapine—Dizziness—Sunitinib—kidney cancer	0.000102	0.000285	CcSEcCtD
Mirtazapine—Feeling abnormal—Gemcitabine—kidney cancer	0.000102	0.000285	CcSEcCtD
Mirtazapine—Shock—Paclitaxel—kidney cancer	0.000101	0.000285	CcSEcCtD
Mirtazapine—Vomiting—Sorafenib—kidney cancer	0.000101	0.000285	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000101	0.000285	CcSEcCtD
Mirtazapine—Nervous system disorder—Paclitaxel—kidney cancer	0.000101	0.000284	CcSEcCtD
Mirtazapine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000101	0.000283	CcSEcCtD
Mirtazapine—Tachycardia—Paclitaxel—kidney cancer	0.000101	0.000282	CcSEcCtD
Mirtazapine—Rash—Sorafenib—kidney cancer	0.000101	0.000282	CcSEcCtD
Mirtazapine—Dermatitis—Sorafenib—kidney cancer	0.000101	0.000282	CcSEcCtD
Mirtazapine—Back pain—Capecitabine—kidney cancer	0.0001	0.000282	CcSEcCtD
Mirtazapine—Skin disorder—Paclitaxel—kidney cancer	0.0001	0.000281	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.0001	0.000281	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.0001	0.000281	CcSEcCtD
Mirtazapine—Headache—Sorafenib—kidney cancer	0.0001	0.000281	CcSEcCtD
Mirtazapine—Hyperhidrosis—Paclitaxel—kidney cancer	9.97e-05	0.00028	CcSEcCtD
Mirtazapine—Diarrhoea—Dactinomycin—kidney cancer	9.95e-05	0.000279	CcSEcCtD
Mirtazapine—Anorexia—Paclitaxel—kidney cancer	9.83e-05	0.000276	CcSEcCtD
Mirtazapine—Gastritis—Doxorubicin—kidney cancer	9.82e-05	0.000276	CcSEcCtD
Mirtazapine—Muscular weakness—Doxorubicin—kidney cancer	9.79e-05	0.000275	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	9.79e-05	0.000275	CcSEcCtD
Mirtazapine—Vomiting—Sunitinib—kidney cancer	9.76e-05	0.000274	CcSEcCtD
Mirtazapine—Body temperature increased—Gemcitabine—kidney cancer	9.74e-05	0.000273	CcSEcCtD
Mirtazapine—Tremor—Capecitabine—kidney cancer	9.72e-05	0.000273	CcSEcCtD
Mirtazapine—Rash—Sunitinib—kidney cancer	9.68e-05	0.000272	CcSEcCtD
Mirtazapine—Dermatitis—Sunitinib—kidney cancer	9.67e-05	0.000271	CcSEcCtD
Mirtazapine—Abdominal distension—Doxorubicin—kidney cancer	9.66e-05	0.000271	CcSEcCtD
Mirtazapine—Hypotension—Paclitaxel—kidney cancer	9.64e-05	0.00027	CcSEcCtD
Mirtazapine—Ill-defined disorder—Capecitabine—kidney cancer	9.62e-05	0.00027	CcSEcCtD
Mirtazapine—Headache—Sunitinib—kidney cancer	9.62e-05	0.00027	CcSEcCtD
Mirtazapine—Influenza—Doxorubicin—kidney cancer	9.59e-05	0.000269	CcSEcCtD
Mirtazapine—Asthma—Doxorubicin—kidney cancer	9.59e-05	0.000269	CcSEcCtD
Mirtazapine—Anaemia—Capecitabine—kidney cancer	9.59e-05	0.000269	CcSEcCtD
Mirtazapine—Hypersensitivity—Vincristine—kidney cancer	9.57e-05	0.000268	CcSEcCtD
Mirtazapine—Eosinophilia—Doxorubicin—kidney cancer	9.5e-05	0.000267	CcSEcCtD
Mirtazapine—Nausea—Sorafenib—kidney cancer	9.48e-05	0.000266	CcSEcCtD
Mirtazapine—Pancreatitis—Doxorubicin—kidney cancer	9.41e-05	0.000264	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.4e-05	0.000264	CcSEcCtD
Mirtazapine—Malaise—Capecitabine—kidney cancer	9.35e-05	0.000262	CcSEcCtD
Mirtazapine—Angina pectoris—Doxorubicin—kidney cancer	9.35e-05	0.000262	CcSEcCtD
Mirtazapine—Insomnia—Paclitaxel—kidney cancer	9.33e-05	0.000262	CcSEcCtD
Mirtazapine—Vertigo—Capecitabine—kidney cancer	9.32e-05	0.000261	CcSEcCtD
Mirtazapine—Asthenia—Vincristine—kidney cancer	9.32e-05	0.000261	CcSEcCtD
Mirtazapine—Syncope—Capecitabine—kidney cancer	9.3e-05	0.000261	CcSEcCtD
Mirtazapine—Leukopenia—Capecitabine—kidney cancer	9.28e-05	0.000261	CcSEcCtD
Mirtazapine—Paraesthesia—Paclitaxel—kidney cancer	9.26e-05	0.00026	CcSEcCtD
Mirtazapine—Vomiting—Dactinomycin—kidney cancer	9.24e-05	0.000259	CcSEcCtD
Mirtazapine—Bronchitis—Doxorubicin—kidney cancer	9.23e-05	0.000259	CcSEcCtD
Mirtazapine—Dyspnoea—Paclitaxel—kidney cancer	9.2e-05	0.000258	CcSEcCtD
Mirtazapine—Somnolence—Paclitaxel—kidney cancer	9.17e-05	0.000257	CcSEcCtD
Mirtazapine—Palpitations—Capecitabine—kidney cancer	9.17e-05	0.000257	CcSEcCtD
Mirtazapine—Rash—Dactinomycin—kidney cancer	9.16e-05	0.000257	CcSEcCtD
Mirtazapine—Nausea—Sunitinib—kidney cancer	9.12e-05	0.000256	CcSEcCtD
Mirtazapine—Loss of consciousness—Capecitabine—kidney cancer	9.12e-05	0.000256	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—kidney cancer	9.11e-05	0.000256	CcSEcCtD
Mirtazapine—Dyspepsia—Paclitaxel—kidney cancer	9.08e-05	0.000255	CcSEcCtD
Mirtazapine—Cough—Capecitabine—kidney cancer	9.05e-05	0.000254	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—kidney cancer	8.97e-05	0.000252	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—kidney cancer	8.97e-05	0.000252	CcSEcCtD
Mirtazapine—Decreased appetite—Paclitaxel—kidney cancer	8.97e-05	0.000252	CcSEcCtD
Mirtazapine—Hypertension—Capecitabine—kidney cancer	8.95e-05	0.000251	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.91e-05	0.00025	CcSEcCtD
Mirtazapine—Fatigue—Paclitaxel—kidney cancer	8.89e-05	0.00025	CcSEcCtD
Mirtazapine—Diarrhoea—Vincristine—kidney cancer	8.89e-05	0.000249	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—kidney cancer	8.86e-05	0.000249	CcSEcCtD
Mirtazapine—Asthenia—Gemcitabine—kidney cancer	8.84e-05	0.000248	CcSEcCtD
Mirtazapine—Arthralgia—Capecitabine—kidney cancer	8.83e-05	0.000248	CcSEcCtD
Mirtazapine—Chest pain—Capecitabine—kidney cancer	8.83e-05	0.000248	CcSEcCtD
Mirtazapine—Myalgia—Capecitabine—kidney cancer	8.83e-05	0.000248	CcSEcCtD
Mirtazapine—Pain—Paclitaxel—kidney cancer	8.82e-05	0.000248	CcSEcCtD
Mirtazapine—Constipation—Paclitaxel—kidney cancer	8.82e-05	0.000248	CcSEcCtD
Mirtazapine—Anxiety—Capecitabine—kidney cancer	8.8e-05	0.000247	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.77e-05	0.000246	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—kidney cancer	8.76e-05	0.000246	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—kidney cancer	8.73e-05	0.000245	CcSEcCtD
Mirtazapine—Discomfort—Capecitabine—kidney cancer	8.72e-05	0.000245	CcSEcCtD
Mirtazapine—Pruritus—Gemcitabine—kidney cancer	8.72e-05	0.000245	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—kidney cancer	8.68e-05	0.000244	CcSEcCtD
Mirtazapine—Dry mouth—Capecitabine—kidney cancer	8.64e-05	0.000242	CcSEcCtD
Mirtazapine—Nausea—Dactinomycin—kidney cancer	8.63e-05	0.000242	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—kidney cancer	8.6e-05	0.000241	CcSEcCtD
Mirtazapine—Dizziness—Vincristine—kidney cancer	8.59e-05	0.000241	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—kidney cancer	8.56e-05	0.00024	CcSEcCtD
Mirtazapine—Confusional state—Capecitabine—kidney cancer	8.54e-05	0.00024	CcSEcCtD
Mirtazapine—Feeling abnormal—Paclitaxel—kidney cancer	8.5e-05	0.000239	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.48e-05	0.000238	CcSEcCtD
Mirtazapine—Oedema—Capecitabine—kidney cancer	8.46e-05	0.000238	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.43e-05	0.000237	CcSEcCtD
Mirtazapine—Diarrhoea—Gemcitabine—kidney cancer	8.43e-05	0.000237	CcSEcCtD
Mirtazapine—Infection—Capecitabine—kidney cancer	8.41e-05	0.000236	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—kidney cancer	8.34e-05	0.000234	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—kidney cancer	8.34e-05	0.000234	CcSEcCtD
Mirtazapine—Shock—Capecitabine—kidney cancer	8.33e-05	0.000234	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—kidney cancer	8.32e-05	0.000233	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—kidney cancer	8.32e-05	0.000233	CcSEcCtD
Mirtazapine—Nervous system disorder—Capecitabine—kidney cancer	8.3e-05	0.000233	CcSEcCtD
Mirtazapine—Thrombocytopenia—Capecitabine—kidney cancer	8.29e-05	0.000233	CcSEcCtD
Mirtazapine—Tachycardia—Capecitabine—kidney cancer	8.26e-05	0.000232	CcSEcCtD
Mirtazapine—Vomiting—Vincristine—kidney cancer	8.26e-05	0.000232	CcSEcCtD
Mirtazapine—Skin disorder—Capecitabine—kidney cancer	8.22e-05	0.000231	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—kidney cancer	8.2e-05	0.00023	CcSEcCtD
Mirtazapine—Urticaria—Paclitaxel—kidney cancer	8.19e-05	0.00023	CcSEcCtD
Mirtazapine—Rash—Vincristine—kidney cancer	8.19e-05	0.00023	CcSEcCtD
Mirtazapine—Hyperhidrosis—Capecitabine—kidney cancer	8.18e-05	0.00023	CcSEcCtD
Mirtazapine—Dermatitis—Vincristine—kidney cancer	8.18e-05	0.00023	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—kidney cancer	8.16e-05	0.000229	CcSEcCtD
Mirtazapine—Body temperature increased—Paclitaxel—kidney cancer	8.15e-05	0.000229	CcSEcCtD
Mirtazapine—Abdominal pain—Paclitaxel—kidney cancer	8.15e-05	0.000229	CcSEcCtD
Mirtazapine—Headache—Vincristine—kidney cancer	8.14e-05	0.000228	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—kidney cancer	8.09e-05	0.000227	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—kidney cancer	8.07e-05	0.000226	CcSEcCtD
Mirtazapine—Anorexia—Capecitabine—kidney cancer	8.07e-05	0.000226	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—kidney cancer	8.03e-05	0.000225	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—kidney cancer	7.98e-05	0.000224	CcSEcCtD
Mirtazapine—Hypotension—Capecitabine—kidney cancer	7.91e-05	0.000222	CcSEcCtD
Mirtazapine—Vomiting—Gemcitabine—kidney cancer	7.83e-05	0.00022	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—kidney cancer	7.82e-05	0.000219	CcSEcCtD
Mirtazapine—Rash—Gemcitabine—kidney cancer	7.77e-05	0.000218	CcSEcCtD
Mirtazapine—Dermatitis—Gemcitabine—kidney cancer	7.76e-05	0.000218	CcSEcCtD
Mirtazapine—Headache—Gemcitabine—kidney cancer	7.72e-05	0.000217	CcSEcCtD
Mirtazapine—Nausea—Vincristine—kidney cancer	7.71e-05	0.000216	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.71e-05	0.000216	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—kidney cancer	7.7e-05	0.000216	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—kidney cancer	7.68e-05	0.000216	CcSEcCtD
Mirtazapine—Insomnia—Capecitabine—kidney cancer	7.66e-05	0.000215	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—kidney cancer	7.64e-05	0.000214	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—kidney cancer	7.62e-05	0.000214	CcSEcCtD
Mirtazapine—Paraesthesia—Capecitabine—kidney cancer	7.6e-05	0.000213	CcSEcCtD
Mirtazapine—Hypersensitivity—Paclitaxel—kidney cancer	7.6e-05	0.000213	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—kidney cancer	7.58e-05	0.000213	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—kidney cancer	7.57e-05	0.000212	CcSEcCtD
Mirtazapine—Dyspnoea—Capecitabine—kidney cancer	7.55e-05	0.000212	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—kidney cancer	7.53e-05	0.000211	CcSEcCtD
Mirtazapine—Dyspepsia—Capecitabine—kidney cancer	7.45e-05	0.000209	CcSEcCtD
Mirtazapine—Asthenia—Paclitaxel—kidney cancer	7.4e-05	0.000208	CcSEcCtD
Mirtazapine—Decreased appetite—Capecitabine—kidney cancer	7.36e-05	0.000206	CcSEcCtD
Mirtazapine—Nausea—Gemcitabine—kidney cancer	7.32e-05	0.000205	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Capecitabine—kidney cancer	7.31e-05	0.000205	CcSEcCtD
Mirtazapine—Fatigue—Capecitabine—kidney cancer	7.3e-05	0.000205	CcSEcCtD
Mirtazapine—Pruritus—Paclitaxel—kidney cancer	7.3e-05	0.000205	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—kidney cancer	7.26e-05	0.000204	CcSEcCtD
Mirtazapine—Pain—Capecitabine—kidney cancer	7.24e-05	0.000203	CcSEcCtD
Mirtazapine—Constipation—Capecitabine—kidney cancer	7.24e-05	0.000203	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—kidney cancer	7.18e-05	0.000201	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—kidney cancer	7.16e-05	0.000201	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—kidney cancer	7.13e-05	0.0002	CcSEcCtD
Mirtazapine—Diarrhoea—Paclitaxel—kidney cancer	7.06e-05	0.000198	CcSEcCtD
Mirtazapine—Feeling abnormal—Capecitabine—kidney cancer	6.98e-05	0.000196	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—kidney cancer	6.97e-05	0.000196	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Capecitabine—kidney cancer	6.92e-05	0.000194	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—kidney cancer	6.89e-05	0.000193	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—kidney cancer	6.86e-05	0.000193	CcSEcCtD
Mirtazapine—Dizziness—Paclitaxel—kidney cancer	6.82e-05	0.000191	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—kidney cancer	6.79e-05	0.00019	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—kidney cancer	6.73e-05	0.000189	CcSEcCtD
Mirtazapine—Urticaria—Capecitabine—kidney cancer	6.72e-05	0.000189	CcSEcCtD
Mirtazapine—Abdominal pain—Capecitabine—kidney cancer	6.69e-05	0.000188	CcSEcCtD
Mirtazapine—Body temperature increased—Capecitabine—kidney cancer	6.69e-05	0.000188	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—kidney cancer	6.69e-05	0.000188	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—kidney cancer	6.59e-05	0.000185	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—kidney cancer	6.56e-05	0.000184	CcSEcCtD
Mirtazapine—Vomiting—Paclitaxel—kidney cancer	6.56e-05	0.000184	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—kidney cancer	6.55e-05	0.000184	CcSEcCtD
Mirtazapine—Rash—Paclitaxel—kidney cancer	6.5e-05	0.000183	CcSEcCtD
Mirtazapine—Dermatitis—Paclitaxel—kidney cancer	6.5e-05	0.000182	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—kidney cancer	6.49e-05	0.000182	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—kidney cancer	6.47e-05	0.000181	CcSEcCtD
Mirtazapine—Headache—Paclitaxel—kidney cancer	6.46e-05	0.000181	CcSEcCtD
Mirtazapine—Hypersensitivity—Capecitabine—kidney cancer	6.24e-05	0.000175	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—kidney cancer	6.2e-05	0.000174	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—kidney cancer	6.18e-05	0.000173	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—kidney cancer	6.14e-05	0.000172	CcSEcCtD
Mirtazapine—Nausea—Paclitaxel—kidney cancer	6.13e-05	0.000172	CcSEcCtD
Mirtazapine—Asthenia—Capecitabine—kidney cancer	6.07e-05	0.00017	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—kidney cancer	6.03e-05	0.000169	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—kidney cancer	6.01e-05	0.000169	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—kidney cancer	6e-05	0.000168	CcSEcCtD
Mirtazapine—Pruritus—Capecitabine—kidney cancer	5.99e-05	0.000168	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—kidney cancer	5.98e-05	0.000168	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—kidney cancer	5.91e-05	0.000166	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—kidney cancer	5.88e-05	0.000165	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—kidney cancer	5.83e-05	0.000164	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—kidney cancer	5.79e-05	0.000163	CcSEcCtD
Mirtazapine—Diarrhoea—Capecitabine—kidney cancer	5.79e-05	0.000163	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—kidney cancer	5.77e-05	0.000162	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—kidney cancer	5.69e-05	0.00016	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—kidney cancer	5.69e-05	0.00016	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—kidney cancer	5.69e-05	0.00016	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—kidney cancer	5.67e-05	0.000159	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.65e-05	0.000159	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—kidney cancer	5.62e-05	0.000158	CcSEcCtD
Mirtazapine—Dizziness—Capecitabine—kidney cancer	5.6e-05	0.000157	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—kidney cancer	5.57e-05	0.000156	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—kidney cancer	5.5e-05	0.000154	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—kidney cancer	5.46e-05	0.000153	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—kidney cancer	5.42e-05	0.000152	CcSEcCtD
Mirtazapine—Vomiting—Capecitabine—kidney cancer	5.38e-05	0.000151	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—kidney cancer	5.37e-05	0.000151	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—kidney cancer	5.35e-05	0.00015	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—kidney cancer	5.34e-05	0.00015	CcSEcCtD
Mirtazapine—Rash—Capecitabine—kidney cancer	5.34e-05	0.00015	CcSEcCtD
Mirtazapine—Dermatitis—Capecitabine—kidney cancer	5.33e-05	0.00015	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—kidney cancer	5.33e-05	0.000149	CcSEcCtD
Mirtazapine—Headache—Capecitabine—kidney cancer	5.3e-05	0.000149	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—kidney cancer	5.3e-05	0.000149	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—kidney cancer	5.27e-05	0.000148	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—kidney cancer	5.2e-05	0.000146	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—kidney cancer	5.1e-05	0.000143	CcSEcCtD
Mirtazapine—Nausea—Capecitabine—kidney cancer	5.03e-05	0.000141	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.97e-05	0.000139	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—kidney cancer	4.94e-05	0.000138	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—kidney cancer	4.9e-05	0.000137	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—kidney cancer	4.86e-05	0.000137	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—kidney cancer	4.85e-05	0.000136	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—kidney cancer	4.8e-05	0.000135	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—kidney cancer	4.74e-05	0.000133	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.71e-05	0.000132	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—kidney cancer	4.7e-05	0.000132	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—kidney cancer	4.67e-05	0.000131	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—kidney cancer	4.67e-05	0.000131	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—kidney cancer	4.5e-05	0.000126	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.46e-05	0.000125	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—kidney cancer	4.33e-05	0.000122	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—kidney cancer	4.31e-05	0.000121	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—kidney cancer	4.31e-05	0.000121	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—kidney cancer	4.02e-05	0.000113	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—kidney cancer	3.91e-05	0.00011	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—kidney cancer	3.86e-05	0.000108	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—kidney cancer	3.73e-05	0.000105	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—kidney cancer	3.61e-05	0.000101	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—kidney cancer	3.47e-05	9.74e-05	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—kidney cancer	3.44e-05	9.65e-05	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—kidney cancer	3.44e-05	9.65e-05	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—kidney cancer	3.42e-05	9.59e-05	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—kidney cancer	3.24e-05	9.09e-05	CcSEcCtD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—kidney cancer	5.24e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB2—kidney cancer	5.24e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.23e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	5.23e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MTOR—kidney cancer	5.2e-06	6.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTEN—kidney cancer	5.2e-06	6.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	5.19e-06	6.41e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	5.18e-06	6.41e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK3—kidney cancer	5.18e-06	6.4e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MTOR—kidney cancer	5.17e-06	6.39e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTP1—kidney cancer	5.16e-06	6.37e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTEN—kidney cancer	5.15e-06	6.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RAF1—kidney cancer	5.15e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RELA—kidney cancer	5.13e-06	6.33e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—kidney cancer	5.12e-06	6.33e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MYC—kidney cancer	5.11e-06	6.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	5.1e-06	6.31e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	5.1e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	5.1e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	5.09e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	5.09e-06	6.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—POMC—kidney cancer	5.07e-06	6.27e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	5.04e-06	6.23e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MYC—kidney cancer	5.03e-06	6.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—kidney cancer	5.03e-06	6.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MTOR—kidney cancer	5.03e-06	6.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—BRAF—kidney cancer	5.01e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MAPK1—kidney cancer	5e-06	6.18e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—BCHE—kidney cancer	5e-06	6.18e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—kidney cancer	5e-06	6.18e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.99e-06	6.17e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—kidney cancer	4.99e-06	6.16e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CDKN1B—kidney cancer	4.99e-06	6.16e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK3—kidney cancer	4.96e-06	6.12e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.94e-06	6.1e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.94e-06	6.1e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK1—kidney cancer	4.93e-06	6.09e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ABCB1—kidney cancer	4.88e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—kidney cancer	4.88e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	4.88e-06	6.02e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—kidney cancer	4.86e-06	6.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.86e-06	6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—JUN—kidney cancer	4.85e-06	6e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	4.85e-06	5.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—kidney cancer	4.84e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—kidney cancer	4.82e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	4.82e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—POMC—kidney cancer	4.82e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—kidney cancer	4.77e-06	5.9e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.77e-06	5.9e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—kidney cancer	4.76e-06	5.88e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—kidney cancer	4.75e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—JUN—kidney cancer	4.75e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTM1—kidney cancer	4.74e-06	5.85e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK3—kidney cancer	4.73e-06	5.85e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—kidney cancer	4.73e-06	5.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.72e-06	5.83e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK1—kidney cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CTNNB1—kidney cancer	4.71e-06	5.82e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.71e-06	5.82e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—kidney cancer	4.69e-06	5.8e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RAF1—kidney cancer	4.67e-06	5.77e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—kidney cancer	4.65e-06	5.75e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—kidney cancer	4.65e-06	5.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RELA—kidney cancer	4.65e-06	5.75e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—kidney cancer	4.65e-06	5.75e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—JUN—kidney cancer	4.64e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.64e-06	5.73e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	4.63e-06	5.72e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—kidney cancer	4.63e-06	5.72e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—kidney cancer	4.62e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	4.62e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—JUN—kidney cancer	4.62e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—kidney cancer	4.62e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	4.61e-06	5.69e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—kidney cancer	4.6e-06	5.69e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RAF1—kidney cancer	4.6e-06	5.68e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—kidney cancer	4.59e-06	5.67e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RAF1—kidney cancer	4.59e-06	5.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.59e-06	5.67e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	4.58e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RELA—kidney cancer	4.58e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RELA—kidney cancer	4.57e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MTOR—kidney cancer	4.56e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.55e-06	5.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—kidney cancer	4.54e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.54e-06	5.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.5e-06	5.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.5e-06	5.56e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK1—kidney cancer	4.5e-06	5.56e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.49e-06	5.55e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.49e-06	5.55e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.49e-06	5.55e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.49e-06	5.55e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.48e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MTOR—kidney cancer	4.48e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.47e-06	5.52e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.46e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.45e-06	5.5e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—kidney cancer	4.45e-06	5.5e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK3—kidney cancer	4.4e-06	5.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.39e-06	5.43e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—kidney cancer	4.34e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	4.34e-06	5.36e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.32e-06	5.34e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—kidney cancer	4.28e-06	5.29e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.28e-06	5.29e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	4.27e-06	5.28e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—kidney cancer	4.25e-06	5.25e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—kidney cancer	4.24e-06	5.24e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—kidney cancer	4.22e-06	5.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.21e-06	5.21e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.21e-06	5.21e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.2e-06	5.19e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—kidney cancer	4.2e-06	5.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—kidney cancer	4.19e-06	5.18e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK1—kidney cancer	4.19e-06	5.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	4.18e-06	5.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RELA—kidney cancer	4.16e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—kidney cancer	4.15e-06	5.12e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	4.14e-06	5.11e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—kidney cancer	4.13e-06	5.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	4.12e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.12e-06	5.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—kidney cancer	4.11e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	4.09e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—kidney cancer	4.08e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	4.08e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—kidney cancer	4.08e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	4.06e-06	5.01e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	4.04e-06	5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—kidney cancer	4.04e-06	4.99e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	4.03e-06	4.99e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—kidney cancer	4.02e-06	4.97e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—kidney cancer	4.01e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—kidney cancer	4.01e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—kidney cancer	4.01e-06	4.95e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—kidney cancer	4e-06	4.94e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.98e-06	4.92e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.98e-06	4.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	3.97e-06	4.91e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—kidney cancer	3.96e-06	4.89e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—kidney cancer	3.96e-06	4.89e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—POMC—kidney cancer	3.95e-06	4.88e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—kidney cancer	3.94e-06	4.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.93e-06	4.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.93e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.92e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—kidney cancer	3.92e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—POMC—kidney cancer	3.92e-06	4.84e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	3.91e-06	4.83e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—kidney cancer	3.9e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.9e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.88e-06	4.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—kidney cancer	3.87e-06	4.78e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—kidney cancer	3.84e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.84e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.83e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.82e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—kidney cancer	3.82e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—kidney cancer	3.82e-06	4.71e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.8e-06	4.69e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—kidney cancer	3.78e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.77e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.75e-06	4.63e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—kidney cancer	3.73e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—kidney cancer	3.73e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.71e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—kidney cancer	3.71e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.69e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.67e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.66e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.66e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.65e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.65e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.62e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.61e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—kidney cancer	3.6e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.56e-06	4.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.53e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.53e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—kidney cancer	3.53e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—kidney cancer	3.52e-06	4.34e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.5e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.5e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.47e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.45e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.43e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.43e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.37e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—kidney cancer	3.35e-06	4.14e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—POMC—kidney cancer	3.35e-06	4.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.34e-06	4.12e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.31e-06	4.1e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	3.31e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.31e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—kidney cancer	3.28e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.24e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—kidney cancer	3.24e-06	4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.22e-06	3.98e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—kidney cancer	3.22e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.2e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—kidney cancer	3.2e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.19e-06	3.94e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	3.17e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.16e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.15e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.15e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	3.15e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.15e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—kidney cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.13e-06	3.86e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	3.09e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	3.06e-06	3.79e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—kidney cancer	3.06e-06	3.79e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—kidney cancer	3.05e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—kidney cancer	3.03e-06	3.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	3.01e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.98e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.98e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—kidney cancer	2.97e-06	3.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.96e-06	3.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.93e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.92e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.87e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.78e-06	3.44e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—kidney cancer	2.75e-06	3.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.74e-06	3.38e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—kidney cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.71e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—kidney cancer	2.69e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.68e-06	3.31e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.65e-06	3.27e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—kidney cancer	2.64e-06	3.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.59e-06	3.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—POMC—kidney cancer	2.58e-06	3.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.41e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.36e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—kidney cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.06e-06	2.55e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.94e-06	2.4e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.92e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—kidney cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.64e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.27e-06	1.57e-05	CbGpPWpGaD
